Diabetes
Weight-loss drugs show early promise for alcohol and other addictions, review finds
Heather Vogel Image generated by AI Fact checked
Medications such as semaglutide (marketed as Ozempic/Wegovy) could aid treatment of alcohol and other substance use disorders, according to a peer‑reviewed review in the Journal of the Endocrine Society. Early animal and human data suggest these GLP‑1 receptor agonists act on brain reward circuits; lead author Lorenzo Leggio urged caution, saying, “Early research in both animals and humans suggests that these treatments may help reduce alcohol and other substance use.”
Calorie-reduced Mediterranean diet lowers diabetes risk by 31 percent
Reported by AI
A large Spanish clinical trial has shown that a calorie-restricted Mediterranean diet combined with exercise and counseling reduces the risk of type 2 diabetes by 31 percent in at-risk adults. The PREDIMED-Plus study followed nearly 5,000 participants over six years, demonstrating significant weight loss and waist reduction. Researchers highlight this approach as a practical, scalable strategy to combat the global diabetes epidemic.
WHO Updates Diabetes Essential Medicines
Reported by AI Fact checked
The World Health Organization has updated its essential medicines list to include key diabetes treatments, improving access to innovative care. Advancements also feature AI-paired devices and smarter insulin systems for better management. These tools aim to enhance monitoring and delay onset in at-risk groups.
Cell Therapy Trial Success for Type 1 Diabetes
In a small cell therapy trial, 10 out of 12 participants with type 1 diabetes no longer required supplemental insulin one year after treatment. This represents a promising advancement in diabetes management.
New Advances in Diabetes Management Technologies
Recent developments in diabetes care include smarter insulin delivery systems and an AI-paired artificial pancreas, highlighted on September 11, 2025.
Study links prediabetes remission to lower diabetes risk without weight loss
Reported by AI
Researchers in Tübingen have found that people with prediabetes can reduce their risk of developing type 2 diabetes by 71% through lifestyle changes that normalize blood sugar levels, even if they do not lose weight. The study emphasizes the role of improved fat distribution over mere weight reduction. This challenges current guidelines focused primarily on shedding pounds.